SB 1037
Modifies provisions relating to naltrexone hydrochloride
LR Number:
Last Action:
3/30/2022 - Voted Do Pass S Seniors, Families, Veterans & Military Affairs Committee
Journal Page:
Calendar Position:
Effective Date:
August 28, 2022

Current Bill Summary

SB 1037 - Under this act, the Director of the Department of Health and Senior Services, if a licensed physician, or a licensed physician on behalf of the Director, may issue a statewide standing order for an addiction mitigation medication, defined as naltrexone hydrochloride administered in a manner approved by the U.S. Food and Drug Administration or any accepted medical practice method of administering.

Any licensed pharmacist may sell and dispense an addiction mitigation medication under a physician protocol or a statewide standing order. A pharmacist who, acting in good faith and with reasonable care, sells or dispenses the addiction mitigation medication and an appropriate device to administer the drug, and the protocol physician, shall not be subject to any criminal or civil liability or professional disciplinary action for prescribing or dispensing the medication and any outcome resulting from the administration of the medication. A physician issuing the statewide standing order shall likewise face no liability or professional discipline relating to the order or administration of the medication.

It shall be permissible for any person to possess an addiction mitigation medication.

This act is identical to provisions in the truly agreed to and finally passed SS/HB 2162 (2022), the truly agreed to and finally passed SS/SCS/HB 2331 (2022), CCS/HCS/SS/SB 690 (2022), and HB 2603 (2022).



No Amendments Found.